Finalist
Ageing Differently with HIV
Summary of work
The UK HIV community of activists and caregivers that fought so hard for positive change in the past is now warning of a potential decline in health and quality of life for the first generation of people with HIV who are increasingly reaching old age. As a pharma company leading the way in HIV innovation, Gilead wanted to inspire people to think positively about solutions to supporting an ageing HIV population.
Through a series of ‘Future Thinkers’ facilitated workshops, the HIV Age Positively programme united HIV leaders with disruptors from outside the field and helped them think differently about how to solve challenges associated with ageing and build their capacity to innovate. A speaker led conference also brought fresh perspectives from the outside in, and fostered a spirit of inspiration and aspiration, where anything is possible. A community grant programme to elevate fresh thinking and innovative practice at grassroots level was also introduced.
The integrated programme raised the priority of ageing on the HIV agenda and inspired HIV stakeholders to propel the next wave of innovation to improve long-term health outcomes, while cementing Gilead’s reputation as a community partner; ranking first among UK patient groups in the Patient View Corporate Reputation Index for best patient group relationships and services beyond the pill.
Judges’ comments
90TEN and Gilead took a creative approach to an old problem and executed very well. Demonstrated that bravery to try something different works.
